Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
HTEC
71
HOLDINGS
26%
ALSO IN WDNA
WDNA
90
HOLDINGS
20%
ALSO IN HTEC
SECTOR DRIFT (HTEC minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HTEC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.4% | 3.0% | 3.0% |
|
NATERA INC | 1.9% | 4.4% | 1.9% |
|
CRISPR THERAPEUTICS AG | 1.8% | 1.5% | 1.5% |
|
UNITED THERAPEUTICS CORP | 1.5% | 2.2% | 1.5% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.5% | 1.5% |
HTEC Overweight Relative to WDNA
 |
JD HEALTH INTERNATIONAL, INC. | 3.2% |
|
GUARDANT HEALTH, INC. | 3.2% |
|
IRHYTHM TECHNOLOGIES, INC. | 3.2% |
 |
EUROFINS SCIENTIFIC | 2.5% |
|
CRYOLIFE INC | 2.4% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
MEDPACE HOLDINGS, INC. | 2.2% |
 |
LONZA GROUP AG-REG | 2.1% |
|
PENUMBRA, INC. | 2.1% |
|
AXOGEN, INC. | 2.1% |
HTEC Underweight Relative to WDNA
|
BRIDGEBIO PHARMA, INC. | -4.0% |
|
BLUEPRINT MEDICINES CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
NATERA INC | -2.5% |
|
STOKE THERAPEUTICS, INC. | -2.3% |
|
ELI LILLY & CO | -2.3% |
|
AGIOS PHARMACEUTICALS INC | -2.1% |
|
IONIS PHARMACEUTICALS, INC. | -2.1% |
|
NOVARTIS AG | -1.9% |
|
GILEAD SCIENCES INC | -1.9% |